3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
3
Recruiting
2
Withdrawn
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Multiple Myeloma
20
Lymphoma
17
Neoplasm Metastasis
14
Leukemia, Myeloid, Acute
12
Pancreatic Neoplasms
9
Breast Neoplasms
9
Ovarian Neoplasms
8
Melanoma
8
Lung Neoplasms
8
Colorectal Neoplasms
8
Sarcoma
7
Prostatic Neoplasms
7
Leukemia, Lymphocytic, Chronic, B-Cell
7
Glioma
7
Fallopian Tube Neoplasms
7
Cholangiocarcinoma
7
Neuroblastoma
6
Lymphoma, Non-Hodgkin
6
Lymphoma, Follicular
6
Endometrial Neoplasms
6
Lymphoma, Large B-Cell, Diffuse
5
Ependymoma
5
Burkitt Lymphoma
5
Wilms Tumor
4
Urinary Bladder Neoplasms
4
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Rhabdomyosarcoma
4
Rhabdoid Tumor
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Interventions
Temozolomide
7
Radiotherapy
6
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Radiation
4
Radiotherapy, Intensity-Modulated
2
Nivolumab
2
vorasidenib
1
veliparib
1
trametinib
1
tocilizumab
1
pembrolizumab
1
fimepinostat
1
dabrafenib
1
atezolizumab
1
abemaciclib
1
Vorinostat
1
Vincristine
1
Spinal Puncture
1
Radiotherapy, Conformal
1
Protons
1
Proton Therapy
1
Procarbazine
1
OKN 007
1
Mycophenolic Acid
1
Lomustine
1
Irinotecan
1
Ipilimumab
1
Immunoglobulin G
1
Disulfides
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Astrocytoma
×
Biopsy
×
Clear all
NCT07031765
2025-12-18
Peds CHAMP1ON
University of Florida
Phase 1
Active not recruiting
12 enrolled